NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Antifungals



Reports summarize antifungals research from University of Heidelberg



November 25th, 2008

"Critically ill patients after extended surgical procedures are Lit high risk for postoperative infections. Fungal infections play a substantial role for immunocompromised patients, e.g. after solid organ transplantation Or under chronic corticoid therapy," scientists in Heidelberg, Germany report.

"Posaconazole, a new broad-spectrum triazole effective against Aspergillus and Candida species as well as many fungi that are resistant to other antifungals, is well tolerated and can be used as an alternative in salvage therapy. Posaconazole can be administered via gavage so that antifungal therapy call be switched from an expensive intravenously applied antifungal to oral...


Source: TB & Outbreaks Week (2008-11-25)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login